AIM ImmunoTech (AIM)
(Delayed Data from AMEX)
$0.38 USD
-0.04 (-8.98%)
Updated Jul 18, 2024 04:00 PM ET
After-Market: $0.39 +0.01 (1.56%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMAIM ImmunoTech Inc. (AIM) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$2.75 | $3.50 | $2.00 | 554.76% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for AIM ImmunoTech Inc. comes to $2.75. The forecasts range from a low of $2.00 to a high of $3.50. The average price target represents an increase of 554.76% from the last closing price of $0.42.
Analyst Price Targets (2 )
Broker Rating
AIM ImmunoTech Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on two recommendations.
Of the two recommendations deriving the current ABR, two are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/12/2024 | Maxim Group | Jason Mccarthy | Strong Buy | Strong Buy |
2/1/2024 | Alliance Global Partners | James Molloy | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 2 |
Average Target Price | $2.75 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 151 of 252 |
Current Quarter EPS Est: | NA |